BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  BioMed Realty Announces First Major Tenant At Gateway Of Pacific, The Latest Expansion Of Life Science, Technology And Healthcare Relationships In Its Bay Area Portfolio

  AbbVie is latest in series of market activity bringing BioMed Realty to Over 1.2 Million Square Feet of Bay Area Leasing in 2018

  November 7, 2018

   · 

  3 min read
• Pharm Country

  InventHelp Inventor Develops Convenient Blood Glucose Monitor (IPL-587)

  The modified device provides a more convenient way to monitor and track blood sugar levels.

  November 7, 2018

   · 

  1 min read
• BioCapital

  airPHX Announces Groundbreaking Advance in Plasma Technology

  Significant Addition to Rapidly Expanding Portfolio of Intellectual Property (IP)

  November 7, 2018

   · 

  2 min read
• Business

  DURECT Corporation Announces Third Quarter 2018 Financial Results and Provides Corporate Update

  Live Webcast of Earnings Call Today at 4:30 p.m. Eastern Time

  November 7, 2018

   · 

  17 min read
• Business

  VolitionRx Limited Announces Third Quarter 2018 Financial Results and Business Update

  VolitionRx Limited today announced financial results and a business update for the quarter ended September 30, 2018.

  November 7, 2018

   · 

  10 min read
• Business

  Hill-Rom Declares Fiscal 2019 First Quarter Dividend

  Hill-Rom Holdings, Inc. announced today that its board of directors declared a fiscal 2019 first quarter dividend of $0.20 per share payable on December 31, 2018, to shareholders of record as of the close of business on December 14, 2018.

  November 7, 2018

   · 

  1 min read
• Business

  Heron Therapeutics Announces Financial Results for the Three and Nine Months Ended September 30, 2018 and Recent Corporate Progress

  Heron Raises Full-Year 2018 CINV Franchise Net Product Sales Guidance to $70 Million to $72 Million

  November 7, 2018

   · 

  9 min read
• Business

  REGENXBIO Reports Third Quarter 2018 Financial and Operating Results and Announces Initiation of Phase I/II Clinical Trial for RGX-121 for the Treatment of MPS II

  Announces first subject dosed in RGX-121 Phase I/II clinical trial for MPS II

  November 7, 2018

   · 

  16 min read
• Jazz Pharmaceuticals Announces Participation at Upcoming November 2018 Investor Conferences

  Jazz Pharmaceuticals plc today announced that the company will be webcasting its corporate presentations at four upcoming investor conferences.

  November 7, 2018

   · 

  2 min read
• Business

  Invitae Reports 106% Annual Revenue Growth Driven by 95% Annual Growth in Volume in Third Quarter 2018

  Raising annual volume and revenue guidance amid strong performance

  November 7, 2018

   · 

  12 min read